Chapter 5 Respiratory drugs - bronchial disorders Flashcards

1
Q

albuterol (ventolin, proventil)
metaproterenol (alupent)
terbutaline (brethaire)
formoterol (perforomist)
pirbuterol (maxair)
bitolterol (tornalate)
levalbuterol (xopenex)
arformoterol (Brovana)

adrenergic bronchodilators

A
  • b2 adrenergic receptor agonist — bronchodilation

indication
* acute asthma sx
* prevent exertion-induced asthma

effects
* vasodilation
* tachycardia
* CNS stimulation
* above all — nonspecific agonists
* ** inhalation preparations fewer side effects **

interactions
* MAO inhibitors
* tricyclic antidepressants
* other sympathoimietcs
* all above can induce toxicity
* beta blockers — inhibit acftivity

bronchodilation less effective in hypoxic and acidotic patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

salmeterol (serevent)

adrenergic bronchodilators

A
  • long acting B2 > b1

indication:
* chronic tx of asthma
* bronchospasm in adults
* NOT for acute exacerbations

effects
* nasopharyngitis (mild infection of the nose and throat that can produce symptoms such as a runny nose, sneezing, and coughing)
* headache/cough

BID dosing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

epinephrine
ephedrine

adrenergic bronchodilators

A
  • b2 receptors - bronchodilation, a1 - vasoconstriction, decreased secretions (epinephrine)
  • a, b1, b2 (ephedrine)

indication
* emergently for severe bronchoconstriction + vasodilation (anaphylaxis)

effects
* tachycardia
* metabolic + GI abnormalities
* CNS stimulation

SUBQ works immediately (epinephrine)
IV for ephedrine

contraindications
* HTN
* hyperthyroidism
* CV insufficiency
* glaucoma

interactions
* MAO inhibitors, tricyclic antidepressants, other sympathomimietics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

isoproterenol (isuprel)

adrenergic bronchodilator

A
  • b1 and b2 agonist

indication:
* similar to epinephrine – severe emergent bronchoconstriction / vasodilation (anaphylaxis) — REQUIRES prescription

effects
* tachycardia
* metabolic and GI abnormalities
* CNS stimulation

inhalation/IV/sublingual

contraindication
* tachycardia

interactions
* MAOIs, tricyclic, sympathomimietics

WITHDRAWAL — may induce relfex bronchoconstriction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Ipratropium (atrovent)
aclidiniuim (tudorza)
umeclidinium (incruse)
tiotropium (spiriva)
reveflenacin (yupelri)

anticholinergic

A
  • muscarinic antagonist
  • reverses acetycholine induced bronchoconstriction

indication
* bronchospasm associated w/ COPD in adults

effects
* few systemic anticholinergic side effects b/c compounds cross into systemic circulation poorly

inhalation

contraindicatoin
* narrow angle glaucoma
* prostatic hypertrophy

additive effects w/ adrenergic agonists

marked in combination w/ albuterol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

theophylline

methylxanthine

A
  • unknown mech
  • @ toxic levels — this can inhibit phosphodiesterase which is an enzyme that breaks down cAMP (2nd messenger that mediates adrenergic induced bronchodilation)
  • methylxantines block adenosine receptors that may account for CNS and cardiac stimulation
  • can also induce diuresis

indication
1) maintenance therapy in moderate-severe asthma
2) slow onset - not good for acute siutation
3) theophylline replaced by ipratropium bromide and/or sympathomimietic agents for non-asthmatic COPD

effects
* n/v
* headache
* insomnia
* tachycardia
* dizziness
* neuromuscular irritability
* seizure
* monitor serum levels!

contraindications
* pt w/ sz disorder
* CV disorder
* peptic ulcer disease

interactions
sympathomimetics – inc heart + CNS toxicity
* cimetidine, oral contraceptives, several antibiotics — inc half life of theophylline => inc toxicity
* dehydration with concurrent use of furosemide

doubling dose … is dangerous b/c it can cause seizures
TX OD with ipecac (syrup), activated charcoal, and cathartic (laxative)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

aminophylline

methylxanthine

A
  • unknown mech
  • @ toxic levels — this can inhibit phosphodiesterase which is an enzyme that breaks down cAMP (2nd messenger that mediates adrenergic induced bronchodilation)
  • methylxantines block adenosine receptors that may account for CNS and cardiac stimulation
  • can also induce diuresis

indication
* IV loading dose for severe, acute bronchoconstriction (theophylline cannot be administered IV

effects
* n/v
* headache
* insomnia
* tachycardia
* dizziness
* neuromuscular irritability
* seizure
* monitor serum levels!

contraindications
* pt w/ sz disorder
* CV disorder
* peptic ulcer disease

interacations
sympathomimetics – inc heart + CNS toxicity
* cimetidine, oral contraceptives, several antibiotics — inc half life of theophylline => inc toxicity
* dehydration with concurrent use of furosemide

this drug is the water soluble salt of theophylline – 78% theophylline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Beclomethasone (beclovent)
budesonide (pulmicort)
fluticasone (flovent)
flunisolide (aerobid)
mometasone (twisthaler)
ciclesonide (zetonna)
triamcinolone (azmacort

corticosteroid

A
  • decrease inflamation and edema in resp tract
  • enhance activity of sympathomimetics in hypoxic and acidotic states

indication
* asthma which cannot be controlled by sympathomimetics (bronchodilators) alone

effects
* usually do not induce systemic toxicity
* action primarily in lungs
* inc risk of oral candida albicans infection (thrush)

inhalation - rapid inactivation in lungs

contraindications
* tx of status asthmaticus (medical emergency, an extreme form of asthma exacerbation characterized by hypoxemia, hypercarbia, and secondary respiratory failure.)
* pt w/ systemic fungal infections

inhalation agents must not be substituted for systemic steroids w/o first tapering systemic steorids (d/c as soon as possible)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

cromolyn (intal)

inflammaotry cell stabilizer

A
  • prevent release of inflammatory mediators (histamine for e.g) from mast cells, macrophages, neutrophils, and eosinophils

indication:
* prophylaxis of asthma attacks
* NOT USEFUL — ongoing attack

effect
* throat irriation

several weeks of therapy for effective prophylaxis — inhalation

MAY allow pts to reduce maintenace dose of brohodilators or corticosteriods

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

zafirlukast (accolate)
montelukast (singulair

lekuotriene receptor antagonists

A
  • competitive antagonists of leukotriene D4/E4 receptors
  • inhibits bronchoconstriction and inflammation

indication
* prophylaxis and chronic asthma

effects
* inc’d respiratory infection in OA
* headache, GI distress

contra
* not for reversal of bronchospasm in acute asthma attacks

interactions
* theophylline + erthromycin reduce zafirlukasts levels
* phenobarbital reduce monetlukast

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

zileuton (zyflo)

leukotriene receptor antagonist

A

inhibits 5-lipxygenase, enzyme for leukoriene synthesis (inflammation and allergic disease)

  • prophylaxis and chronic asthma tx

effects
* headache
* Liver enzyme elevation
* GI

Contra
* not for reversal of bronchospasm in acute asthma attacks

interations
* inc serum tehophylline level

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

benralizumab (fasenra)
mepolizumab (nucala)
reslizumab (cinqair)

leukotriene receptor antagonist

A
  • monoclonal antibody that binds interluekin-5 receptor on eosinophils + basophils (contribute to asthma) l/t NK cell mediated death

indication
* maintenance asthma therapy
* not for acute asthma exacerbations

effects
* hypersensitivity rxn to drug

very long serum half life (benra + mepo)
IV (resliz)

contraindications:
for benra and mepo — avoid patients with helminthic infection (eosinophils clear helminths) — parasitic worms

DO NOT WEAN STEROIDS TOO RAPIDLY AFTER STARTING THIS DRUG 1st two on this list

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

surfacant (exosurf, survanta)

miscellanoues

A
  • infant respiratory distress syndrome – d/t lack of surfactant; crucial for decreasing surface tension in lungs, premit alveoli to open more readily
  • administerd endotracheally to reduce incidence and severity of IRDS
  • Toxicity — desaturation and bradycardia during administration and risk of pulmonary hemorrhage
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

n-acetylcysteine (mucomyst)

misc

A

mucolytic agent
* reduce viscoity of mucous by cleaving protein complexes
* indication - chronic bronchopulmonary disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

alpha, proteinase inhibitor (prolastin)

misc

A
  • pt w/ alpha1 antitrypsin deficiency (condition that raises your risk for lung and other diseases. AAT is a protein made in your liver to help protect the lungs. If your body does not make enough AAT, your lungs are more easily damaged from smoking, pollution, or dust from the environment. This can lead to COPD) develop pan acinar emphysema d/t degradation of elastin by neutrophil-produced elastase (major inflammatory protease released by neutrophils and is present in the airways of patients with cystic fibrosis (CF), chronic obstructive pulmonary disease, non-CF bronchiectasis, and bronchopulmonary dysplasia)
  • given this drug IV each week
  • primary toxicity - fever
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

palivizumab (synagis)

misc

A
  • humanized monoclonal antibody => RSV (respiraotyr syncytial virus)
  • provides passive immunity for high risk infants (premature, bronchopulmonary dysplasia) when given monthly IM shots during winter and early spring months when RSV infections are prevalent in community
17
Q

Beclomethasone (becanase)
budesonide (rhinocort)
ciclesonide (omnaris)
flunisolide (nasalide)
triamcinolone (nasacort)
fluticasone (flonase)
mometasone (nasonex)

misc / intranasal steroids

A
  • inhibits inflammtory cells in nasal muscoa
  • reduce rhinitis sx
  • risk — thrush (oropharyngeal candida) and inihbit healing of damaged nasal cannula
18
Q
A